Literature DB >> 26293584

Cognitive impairment in remitted and non-remitted depressive patients: A follow-up comparison between first and recurrent episodes.

Miquel Roca1, Emilio López-Navarro2, Saray Monzón3, Margalida Vives2, Mauro García-Toro2, Javier García-Campayo4, John Harrison5, Margalida Gili2.   

Abstract

Cognitive impairment is a core symptom of depressive disorders associated with poor social function. New research is needed to analyze depression-related symptoms in cognitive impairment and to observe if they are reversible or not during clinical remission in patients with or without previous episodes. None of the previous studies has analyzed the differences between first and recurrent episodes in a long-term follow-up study related with remission state. The aim of our study was to compare cognitive performance and assess the impact of previous depressive episodes in a sample of patients in acute phase and in remission six month later. 79 depressive patients were assessed at baseline. The instruments used for clinical and cognitive assessment were: Hamilton Depression Rating Scale, Mini-Mental State Examination and the Clinical Global Impression Rating Scales, Trail Making Test parts A and B, Digital Span subtest of WAIS, Stroop Colour Word Test, Tower of London, Controlled Verbal Fluency Task, Semantic Verbal Fluency and Finger Tapping Test. A repeated measures MANCOVA with education as covariate was used. No differences were found at baseline between first episode and recurrent depressive patients. At six month, remitted patients scored significant better in TMT-A, TMT-B, Animals and Tower of London total time. Remitted first depressive patients scored significant worse than remitted recurrent depressive patients. The main finding of the study is the effect of remission on cognitive function despite previous episodes. However first episode remitted patients seemed to have poor access to long term memory than recurrent remitted patients.
Copyright © 2015 Elsevier B.V. and ECNP. All rights reserved.

Entities:  

Keywords:  Clinical remission; Cognition; Executive functions; Major depressive disorder; Recurrent depression

Mesh:

Substances:

Year:  2015        PMID: 26293584     DOI: 10.1016/j.euroneuro.2015.07.020

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  9 in total

Review 1.  Neurocognitive deficits in depression: a systematic review of cognitive impairment in the acute and remitted state.

Authors:  Dominik Kriesche; Christian F J Woll; Nadja Tschentscher; Rolf R Engel; Susanne Karch
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-09-01       Impact factor: 5.760

2.  Association Between Depression and Antiretroviral Therapy Use Among People Living with HIV: A Meta-analysis.

Authors:  Jun Tao; Sten H Vermund; Han-Zhu Qian
Journal:  AIDS Behav       Date:  2018-05

3.  Altered Brain Function in First-Episode and Recurrent Depression: A Resting-State Functional Magnetic Resonance Imaging Study.

Authors:  Jifei Sun; Limei Chen; Jiakai He; Zhongming Du; Yue Ma; Zhi Wang; Chunlei Guo; Yi Luo; Deqiang Gao; Yang Hong; Lei Zhang; Fengquan Xu; Jiudong Cao; Xiaobing Hou; Xue Xiao; Jing Tian; Jiliang Fang; Xue Yu
Journal:  Front Neurosci       Date:  2022-04-25       Impact factor: 4.677

4.  Altered fractional amplitude of low frequency fluctuation associated with cognitive dysfunction in first-episode drug-naïve major depressive disorder patients.

Authors:  Manli Huang; Shaojia Lu; Liang Yu; Lingjiang Li; Peng Zhang; Jianbo Hu; Weihua Zhou; Shaohua Hu; Ning Wei; Jinwen Huang; Jian Weng; Yi Xu
Journal:  BMC Psychiatry       Date:  2017-01-11       Impact factor: 3.630

5.  The involvement of potassium channel ORK1 in short-term memory and sleep in Drosophila.

Authors:  Xiaoyan Zhang; Yabin Zheng; Qingguo Ren; Hong Zhou
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

6.  Evidence for Progressive Cognitive Deficits in Patients With Major Depressive Disorder.

Authors:  Jin Liu; Bangshan Liu; Mi Wang; Yumeng Ju; Qiangli Dong; Xiaowen Lu; Jinrong Sun; Liang Zhang; Hua Guo; Futao Zhao; Weihui Li; Li Zhang; Zexuan Li; Yan Zhang; Mei Liao; Lingjiang Li
Journal:  Front Psychiatry       Date:  2021-02-16       Impact factor: 4.157

Review 7.  Cognitive Impairment and Neurocognitive Profiles in Major Depression-A Clinical Perspective.

Authors:  Åsa Hammar; Eivind Haga Ronold; Guro Årdal Rekkedal
Journal:  Front Psychiatry       Date:  2022-03-08       Impact factor: 4.157

8.  Variation in Recent Onset Parkinson's Disease: Implications for Prodromal Detection.

Authors:  Diane M A Swallow; Michael A Lawton; Katherine A Grosset; Naveed Malek; Callum R Smith; Nin P Bajaj; Roger A Barker; Yoav Ben-Shlomo; David J Burn; Thomas Foltynie; John Hardy; Huw R Morris; Nigel Williams; Nicholas W Wood; Donald G Grosset
Journal:  J Parkinsons Dis       Date:  2016-03-19       Impact factor: 5.568

9.  Stability, reliability, and validity of the THINC-it screening tool for cognitive impairment in depression: A psychometric exploration in healthy volunteers.

Authors:  John E Harrison; Harry Barry; Bernhard T Baune; Michael W Best; Christopher R Bowie; Danielle S Cha; Larry Culpepper; Philippe Fossati; Tracy L Greer; Catherine Harmer; Esther Klag; Raymond W Lam; Yena Lee; Rodrigo B Mansur; Hans-Ulrich Wittchen; Roger S McIntyre
Journal:  Int J Methods Psychiatr Res       Date:  2018-08-07       Impact factor: 4.035

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.